| Ytd | -35.58% | |
| 1y | -20.33% |
| Open | 7.46 | Prev Close | 7.51 | Low | 7.46 | High | 7.74 | Mkt Cap | 492.94M |
| Vol | 560.05K | Avg Vol | 788.21K | EPS | 0.26 | P/E | 29.38 | Forward P/E | -1.78 |
| Beta | 1.96 | Short Ratio | 11.90 | Inst. Own | 110.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 8.56 | 200-d Avg | 10.05 | 1yr Est | 58.55 |
ARVN News
– Data showed improvements in an objective measure of impaired eye movement associated with Parkinso
Arvinas, Inc. (NASDAQ:ARVN), a clinical-stage biotechnology company creating a new class of drugs ba
Arvinas (NASDAQ:ARVN) reported second-quarter financial results on Tuesday. The transcript from the
Evercore ISI Group analyst Jonathan Miller maintains Arvinas (NASDAQ:ARVN) with a Outperform and
Citigroup analyst Yigal Nochomovitz maintains Arvinas (NASDAQ:ARVN) with a Buy and lowers the pri
Wells Fargo analyst Derek Archila downgrades Arvinas (NASDAQ:ARVN) from Overweight to Equal-Weigh
Wedbush analyst Robert Driscoll maintains Arvinas (NASDAQ:ARVN) with a Neutral and raises the pri
Arvinas (NASDAQ:ARVN) reported second-quarter financial results on Tuesday. The transcript from the
Arvinas (NASDAQ:ARVN) reported quarterly earnings of $2.58 per share which beat the analyst consensu
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a commercial stage biotechnology company focused on hemat
Arvinas Inc (NASDAQ:ARVN) reported Q1 losses of 90 cents/share, missed analyst estimates. Rigel Phar
Top Wall Street analysts updated their ratings on top companies. For full list of changes, including
Rigel Pharmaceuticals stock jumps after signing a VEPPANU licensing deal with Arvinas and Pfizer fol
Arvinas, Inc. (NASDAQ:ARVN), a biotechnology company creating a new class of drugs based on targeted
Pfizer and Arvinas secure FDA approval for VEPPANU (vepdegestrant), a first-of-its-kind treatment fo
U.S.
Shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) moved lower during Friday’s session follow
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azent
On Wednesday, 311 stocks hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
On Monday, 369 companies set new 52-week lows.
During Wednesday's session, 212 companies made new 52-week lows.
During Tuesday's morning session, 137 companies made new 52-week lows.
On Thursday, 498 companies reached new 52-week lows.
Friday's session saw 104 companies set new 52-week lows.
On Thursday, 185 companies achieved new lows for the year.
On Friday, 469 companies hit new 52-week lows.
Companies That Fell Through 52-Week Lows Monday During Monday's morning trading, 14 companies s
Thursday's session saw 329 companies set new 52-week lows.
Gainers
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company an
On Tuesday, 951 companies hit new 52-week lows.